Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathways

There is a current requirement for novel therapeutic strategies for the treatment of hematopoietic tumors. Residual tumor cells are the main origin of tumor relapse. The aim of this study was to eliminate the residual tumor cells of hematopoietic tumors. Cytokine-induced killer (CIK) cells are used...

Descripción completa

Detalles Bibliográficos
Autores principales: DENG, QI, BAI, XUE, LV, HAI-RONG, XIAO, XIA, ZHAO, MING-FENG, LI, YU-MING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353788/
https://www.ncbi.nlm.nih.gov/pubmed/25780412
http://dx.doi.org/10.3892/etm.2015.2264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353788/
https://www.ncbi.nlm.nih.gov/pubmed/25780412
http://dx.doi.org/10.3892/etm.2015.2264

Ejemplares similares